Safety concerns and trial holds for pediatric RSV vaccines prompt caution from FDA adcomm
FDA advisors review concerning safety data from Moderna’s pediatric RSV vaccine trials, with severe cases leading to clinical holds. Committee suggests further trials needed to understand immune responses in children.